Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue November 2015
 •  The Laundress Opens Flagship Store  •  New Anti-Aging Active at Silab  •  Innospec Attains Cosmetic GMP Certification  •  Herbalife Clears Another Legal Hurdle  •  Mary Kay Picks Location for New R&D Center

PBA, ICMAD Respond to FDA

Published May 2, 2014
Related Searches: industry fda professional president
Post a comment
For more than a year, top beauty industry organizations, the Professional Beauty Association (PBA) and Independent Cosmetic Manufacturers and Distributors (ICMAD), have been working collaboratively with the FDA to create much needed modernized and comprehensive federal regulations of the cosmetics industry for the first time since the 1960s.

On March 6, the FDA issued an unforeseen public letter criticizing these industry organizations and their ongoing efforts to create this challenging yet vital legislation.

In response to the FDA letter, PBA and ICMAD issued the following rebuttal from Pamela Jo Busiek, president and CEO, ICMAD, and Steve Sleeper, executive director, Professional Beauty Association:

“We are disappointed with the FDA’s letter stating that they have precipitously decided to discontinue negotiations with the cosmetics industry regarding legislation to modernize national cosmetic legislation. Our industry organizations met in good faith for over a year with the FDA, and were diligently working to reach a framework, which we still hope to achieve, that would be the basis for a new legislative initiative.”  

blog comments powered by Disqus